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Dr Toni Lerut (Leuven, Belgium). It is a privilege for me to dis-
cuss this excellent and important presentation reporting an in-depth
study on the results of what is now by far the largest series on re-
pairs of GPEH. The conclusion is that laparoscopic repair provides
excellent patient satisfaction and symptom resolution, with reoper-
ation rates comparable to those of the best open series. Despite your
obvious enthusiasm, Dr Luketich, I do have some concerns and
questions.
This surgery remains to be considered as a complex and major
surgery, with duration of intervention, major complication rates,
and mortality figures equaling those now obtained for esophagec-
tomy in centers of excellence, in fact 1.4% for your own center.
The overall reintervention rate, including reoperation for recur-
rence, was 8% in this series, whereas recurrence remains as high
as 15%. Although patient satisfaction reached 90%, a detailed anal-
ysis of your data indicates that postoperative symptoms such as
dysphagia, heartburn, and bloating are recurring in about 1 in 4
cases, and the need for proton pump inhibitor continuation is as
high as 40%. So to me it appears that we are not yet there. I have
3 questions.
First, your 30-day mortality was 1.7%, but overall 85 patients
died during follow-up. Because half of the patients in your series
were older than 70 years or had a CCI score of 3 or more, what
were the 6-month and 1-year mortalities, which in fact reflect
much more better the true postoperative mortality?
Second, Stylopoulos and Rattner in 2002, with a Markov Monte
Carlo decision analytic model, calculated that for the many patients
with minor symptoms, such as heartburn, bloating, and so on, a pol-
icy of watchful waiting entails a lifetime risk of development of
acute symptoms requiring surgery estimated at 1.1% per year,
with mortality related to emergency surgery of 5.4%. So they cal-The Journal of Thoracic and Caculated an overall lifetime risk of dying of paraesophageal hernia
in a patient managed by watchful waiting to be 1%, which is less
than the 30-day mortality in your series. Given these data, and
given the high comorbidity in your population, your median age
of 70 years, the substantial postoperative complications and read-
mission rate, and the 8% mortality rate among patients older than
80 years, what according to your experience are now the guidelines
for this subset of patients?
Dr Luketich. Could you just summarize that second question? I
didn’t quite hear the question at the end.
Dr Lerut.Given Rattner’s data and the high comorbidity in your
population, your median age of 70 years, your high readmission
and complication rate, and the high postoperative mortality in pa-
tients older than 80 years, what are your guidelines for this subset
of patients?
Dr Luketich. Guidelines for entry for elective repair?
Dr Lerut. Exactly.
Dr Luketich. I see.
Dr Lerut. Finally, the recurrence rate was 15%. Could you tell us
whether in this subset of patients you performed with time subse-
quent barium esophagography? If so, did this show further progres-
sion of the size of such intrathoracic migration, particularly in the
group of younger patients who seem to bemore at risk for recurrence
simply by virtue of surviving longer than the elderly group?What is
the scheme, the algorithm, for follow-up in those cases?
Dr Luketich. Thank you, Dr Lerut. To the first question, the
mortalities at 6 months and 1 year, I can’t give you those data.
We looked primarily at 30-day mortality. Certainly in looking
at this group of elderly patients, there are obviously natural deaths
occurring in significant numbers among these patients with time.
What we did find was that if the CCI score was low and the pa-
tient was younger than 70 years, or even older than 70 years with
a low CCI score, the 30-day mortality was nil. I hope that
answers that question. We do have the data to look more closely
at exactly which patients died of at 6 months and 1 year, but it
was clear that these deaths did not appear to be related to the
operation.
I’ll answer the last question next, because I am not sure I under-
stand or can answer the second question. Looking at those small ra-
diographic recurrences, no doubt they are a significant concern. If
we try and repair a hiatal hernia, an incisional hernia, or a groin her-
nia and have any type of hernia recurrence, we are always con-
cerned that it is going to lead to a larger recurrence, then
potential symptoms, and then reoperation. I can tell you that
when we looked at that first subset of patients back in 2000,
when Andrew Pierre presented those data, we had a reoperative
rate of around 2%. Those patients have a follow-up now of 77
months, with a reoperation rate up to 4%. I think that may be where
the rate is peaking. That is what it looks like to us; most of the re-
currences that require reoperation are within 2 to 3 years. Once we
get beyond that, we seem to see very few. There will be some, I am
certain, and we have seen a few, but not many. And even in this ar-
ticle, when you look at the early data compared to the late data, it
does appear that there is some stability of that radiographic recur-
rence.
In looking back at the laparoscopic randomized trial that was
presented at the American Surgical Society meeting a couple of
years ago, those were 6-month data showing 9% radiographicrdiovascular Surgery c Volume 139, Number 2 403
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data have not been presented on that, but it will be interesting to see
how many of those recurrences become symptomatic and how
many require reoperation with mesh. We have tried to present
that, most recently at the Digestive Disease Week, with our 77-
month follow-up, as I mentioned.
In terms of establishing better guidelines for elective repair and
looking at the likelihood of significant symptoms and whether these
patients should undergo surgery or maybe would best be consid-
ered for medical treatment, a variety of indexes have been proposed
to address this question. In our clinics, what we are seeing is primar-
ily referral for symptoms, for specific problems, whether anemia,
dysphagia, pain, heartburn, or whatever. Although there is no doubt
that some of those patients still have symptoms after the surgery,
what isn’t known or is difficult to assess is the level of the symp-
toms. That is, results are less meaningful if you look merely at pres-
ence or absence of dysphagia, versus an index of occasional
problems with hard solids. A significant number of the patients
fall into that category; they are eating a regular diet but have occa-
sional dysphagia with hard solids. I think part of that is related to the404 The Journal of Thoracic and Cardiovascular SurgCollis gastroplasty. It does lead to a small segment of relatively
amotile neoesophagus, and that can dilate with time. No doubt,
the Collis gastroplasty carries some significant limitations. In lieu
of getting that tension-free segment of intra-abdominal esophagus,
however, it is probably the best approach to that group of patients
short of further esophageal mobilization. We have not really
changed our guidelines, but we are trying now to evaluate those
symptoms more closely, because it is clear that some of them are
present. All decrease significantly with time. And the one thing
that is important to look at is the final analysis of surgical satisfac-
tion and the final analysis of the GERD-HRQoL score being 90%
improved.
So we don’t have the answer to some of those questions. I can
tell you that we are looking at the issue and trying to study it
more carefully. We have established detailed questionnaires, and
it takes significant amounts of time and money to follow each of
these questions carefully with time and try to assign a score, rather
than a yes or no. Most of these patients do seem very satisfied, very
happy, even when they come to the postoperative clinics with some
of these symptoms present.ery c February 2010
